written on 20.06.2014
Tags:
,

Evaluating GMP Legislation in the Pharmaceutical Supply Chain

TAGS: ,

Over the past year, the global pharmaceutical supply chain has seen transformation under newly implemented regulatory legislation, such as the Falsified Medicines Directive (FMD) in Europe. This legislation has increased the significance of local agency oversight and the importance of strong supplier relationships. In just over 100 days, the largest pharmaceutical ingredient event of the […]

Latest Report